Results 1 to 10 of about 95,231 (289)

Polypharmacy is a risk factor for disease flare in adult patients with ulcerative colitis: a retrospective cohort study [PDF]

open access: yesIntestinal Research, 2019
Background/Aims Polypharmacy is a common clinical problem with chronic diseases that can be associated with adverse patient outcomes. The present study aimed to determine the prevalence and patient-specific characteristics associated with polypharmacy in
Jingzhou Wang   +3 more
doaj   +1 more source

Polypharmacy, Adverse Outcomes, and Treatment Effectiveness in Patients ≥75 With Atrial Fibrillation

open access: yesJournal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2020
Background Polypharmacy is highly prevalent in elderly people with chronic conditions, including atrial fibrillation (AF). The impact of polypharmacy on adverse outcomes and on treatment effectiveness in elderly patients with AF remains unaddressed ...
Nemin Chen   +7 more
doaj   +1 more source

Prevalence and predictors of polypharmacy among Korean elderly.

open access: yesPLoS ONE, 2014
ObjectivePolypharmacy is widespread in the elderly because of their multiple chronic health problems. The objective of this study was to investigate the prevalence and predictors associated with polypharmacy in a nationally representative sample of ...
Hong-Ah Kim   +3 more
doaj   +1 more source

Prevalence and Age Structure of Polypharmacy in Poland: Results of the Analysis of the National Real-World Database of 38 Million Citizens

open access: yesFrontiers in Pharmacology, 2021
Introduction: Polypharmacy is a risk factor for adverse health outcomes, higher use of medical services and additional costs. The problem has gained attention as a consequence of aging and related multimorbidity.
Przemysław Kardas   +5 more
doaj   +1 more source

Polypharmacy among community-dwelling elderly in Singapore: Prevalence, risk factors and association with medication non-adherence

open access: yesProceedings of Singapore Healthcare, 2019
Background: Polypharmacy, given its link with drug interactions, potentially inappropriate medications and medication non-adherence, may pose a significant health risk, especially among the elderly.
Yi Wen Tan   +3 more
doaj   +1 more source

Polypharmacy and the coproduction of the experience between physicians and patients

open access: yesTeoria e Prática em Administração, 2021
Purpose: To identify how physicians can help polypharmacy patients deal with their disease condition by focusing on the non-clinical factors of care processes.
Md Mafuzul Huq   +2 more
doaj   +1 more source

What is polypharmacy? A systematic review of definitions

open access: yesBMC Geriatrics, 2017
Background Multimorbidity and the associated use of multiple medicines (polypharmacy), is common in the older population. Despite this, there is no consensus definition for polypharmacy.
Nashwa Masnoon   +3 more
doaj   +1 more source

Is shared decision-making a determinant of polypharmacy in older patients with chronic disease? A cross-sectional study in Hubei Province, China

open access: yesBMC Geriatrics, 2023
Background Shared decision-making(SDM) is recognized as an important means of managing polypharmacy among older people with chronic diseases. However, no studies have quantitatively measured the effect of SDM on polypharmacy.
Qiao Zong   +5 more
doaj   +1 more source

Polypharmacy in African American Adults: A National Epidemiological Study

open access: yesPharmacy, 2019
Background: Despite the association between polypharmacy and undesired health outcomes being well established, very little is known about epidemiology of polypharmacy in the African American community.
Shervin Assari   +2 more
doaj   +1 more source

Prevalence and determinants of polypharmacy in cardiovascular patients attending outpatient clinic in Ethiopia University Hospital.

open access: yesPLoS ONE, 2020
BACKGROUND:While there are advances in medicine and pharmaceutical care, the burden of medication use has also grown with polypharmacy. In this regard, cardiovascular patients are subjected to polypharmacy for a longer period. OBJECTIVE:The present study
Yonas Getaye Tefera   +2 more
doaj   +1 more source

Home - About - Disclaimer - Privacy